Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

Leadership

Last Updated: May 14, 2019; Last Reviewed: May 14, 2019

Leadership
Member Financial Disclosure
Company Relationship
Benson, Constance University of California, San Diego Dr. Benson has served on an advisory and a data monitoring board for GlaxoSmithKline/ViiV Healthcare and received research grants awarded to her institution from Gilead Sciences, Inc. Her spouse has served as a consultant to CytoDyn, Gilead Sciences, Inc, Pfizer, and Vir Biotechnology; has received grant support from Gilead Sciences, Inc; and holds stock or stock options in Antiva Biosciences and CytoDyn.
Brooks, John T. Centers for Disease Control and Prevention None N/A
Holmes, King  University of Washington School of Medicine Merck Honoraria
Masur, Henry National Institutes of Health None N/A
Pau, Alice National Institutes of Health None N/A

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from May 1, 2017, through May 1, 2019. 

Download Guidelines